Skip to content
  • Home
  • Newsroom
  • ...
  • 06
  • Australia to Switzerland – global research back in person

Australia to Switzerland – global research back in person

men and women smiling
Dr Anil D’Cruz, President of UICC, HRH Princess Dina Mired of Jordan, Global Health Ambassador, Anne Lise Ryel, President of the Non Communicable Disease Alliance and University of Southern Queensland Professor Jeff Dunn OAM, taken at the Bloomberg Philanthropy side event at the World Health Assembly.

Following a lengthy travel hiatus, Professor of Cancer Survivorship at the University of Southern Queensland, Jeff Dunn, has visited the Union for International Cancer Control (UICC) in Geneva, Switzerland for the first time in two years.

In his role as President-Elect for the UICC, Professor Dunn spent a week in Geneva in late May to assist in planning for the World Cancer Congress to be held later this year, present on his latest research study, attend a Bloomberg Philanthropy event at the World Health Assembly, meet with the Foundation Partners of the Non-Communicable Disease Alliance (NCDA) and launch a new global partnership,

“While in Geneva I had the great honour of participating in launching the Access to Oncology Medicines Coalition which will help countries develop the capacity for the proper handling to quality-assured essential cancer medicines in low- and lower middle-income countries (LLMICs) and improve their affordability and sustainable supply,” Professor Dunn said.

“It’s a ground-breaking opportunity to improve cancer outcomes in LLMICs, and it’s a remarkable achievement to bring together such a broad range of excellent partners, which will allow us to address the many challenges we face in making sure that people with cancer in target countries receive the medicines they need, when they need them.”

Professor Dunn also addressed the UICC on a new model of care - Prostate Cancer Survivorship Essentials, or PCEssentials – that integrates evidence-based strategies to improve men’s quality of life outcomes after hormone therapy in a men-centred approach where personal agency intersects with all aspects of care.

“PCEssentials is a National Health and Medical Research Council Partnership Project led by the University of Southern Queensland the Prostate Cancer Foundation of Australia and is a world-first study of its kind,” he said.

“We want to implement and test the new PCEssentials intervention for men with prostate cancer undergoing hormone therapy to identify if it improves the quality of life for men and their ability to support their own health and wellbeing.

“It’s always incredibly humbling to have the platform to talk to a global audience about world-first research that’s being led from a regional base by the University of Southern Queensland – it makes me very proud.”

From Queensland to the World: follow our new #whereintheworld campaign and explore just how far the University of Southern Queensland global reach extends to.
Proudly Australia’s leading regional university, the University of Southern Queensland is home to some of the most vibrant hubs of education excellence and research innovation in the world.

We’re committed to solving problems that matter, with local solutions to global challenges, where our researchers are leading the way in next generation innovation and inspiring students who are future focused.